Profit Margin Summary (Annual)

According to bioAffinity Technologies's latest annual financial reports, the company has an operating profit margin of -314.84%. This metric indicates the percentage of revenue that remains after deducting operating expenses, excluding interest and taxes.

The company's gross profit margin stands at 21.40%, reflecting the percentage of revenue that exceeds the cost of goods sold (COGS).

The pretax profit margin is -312.58%, indicating the percentage of revenue that remains after deducting all expenses except taxes.

Lastly, the net profit margin is -313.41%, which shows the percentage of revenue that remains as profit after all expenses, including taxes, have been deducted.

The trailing twelve months (TTM) operating profit margin is -118.51%, providing a more up-to-date view of the company's financial health.

Historical Operating Profit Margin

Historical Gross Profit Margin

Historical Pretax Profit Margin

Historical Net Profit Margin

bioAffinity Technologies Historical Profit Margins

bioAffinity Technologies Profit Margin History

The table below shows the margins for each year, with the latest data available for the last fiscal year 2023.